TransMedics Group, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2025: USD 21.59 M

TransMedics Group, Inc. Depreciation And Amortization is USD 21.59 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 89.55% change year over year. Depreciation and amortization are expense that reduces the value of tangible and intangible assets over their useful lives for tax and reporting purposes.
  • TransMedics Group, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 11.39 M, a 167.54% change year over year.
  • TransMedics Group, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 4.26 M, a 126.61% change year over year.
  • TransMedics Group, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 1.88 M, a 13.81% change year over year.
  • TransMedics Group, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 1.65 M, a 22.48% change year over year.
Key Data
Date Depreciation And Amortization Dividends Paid Common Stock Issued Common Stock Repurchased